rec. | Subject | Hit Length | Description | Align.Len | E value | Bit score | % ident. | % pos. | GO associations |
211 | P05406 | 278 | FIXR_BRAJA Protein fixR OS=Bradyrhizobium jap... | 256 | 0.000000000000005 | 75.9 | 29 | 44 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | GO:0009399; P:nitrogen fixation; IEA:UniProtKB-KW. | 212 | Q8NUV9 | 231 | Y2403_STAAW Uncharacterized oxidoreductase MW... | 196 | 0.000000000000008 | 74.7 | 29 | 51 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 213 | Q6G6J1 | 231 | Y2370_STAAS Uncharacterized oxidoreductase SA... | 196 | 0.000000000000008 | 74.7 | 29 | 51 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 214 | P71824 | 248 | Y769_MYCTU Uncharacterized oxidoreductase Rv0... | 259 | 0.000000000000008 | 75.1 | 30 | 47 | GO:0005886; C:plasma membrane; IDA:MTBBASE. | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 215 | P40398 | 299 | YHXD_BACSU Uncharacterized oxidoreductase yhx... | 256 | 0.000000000000008 | 75.9 | 29 | 43 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 216 | Q75KH3 | 300 | GRDH_ORYSJ Glucose and ribitol dehydrogenase ... | 266 | 0.000000000000009 | 75.5 | 26 | 47 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 217 | Q49117 | 248 | Y182_METEA Uncharacterized oxidoreductase Mex... | 254 | 0.000000000000009 | 74.7 | 26 | 46 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 218 | Q22230 | 309 | YVX3_CAEEL Uncharacterized oxidoreductase T05... | 267 | 0.000000000000009 | 75.9 | 28 | 45 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 219 | P54795 | 257 | MOAE_ENTAE Protein moaE OS=Enterobacter aerog... | 152 | 0.00000000000001 | 74.7 | 32 | 54 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 220 | P50206 | 276 | BPHB_PSES1 Cis-2,3-dihydrobiphenyl-2,3-diol d... | 265 | 0.00000000000002 | 74.7 | 28 | 42 | | | | | | | | | | | GO:0018509; F:cis-2,3-dihydrobiphenyl-2,3-diol dehydrogenase activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW. | 221 | Q9GME3 | 134 | DHB8_CALJA Estradiol 17-beta-dehydrogenase 8 ... | 139 | 0.00000000000002 | 72 | 37 | 52 | GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0004303; F:estradiol 17-beta-dehydrogenase activity; ISS:UniProtKB.::GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0050327; F:testosterone 17-beta-dehydrogenase (NAD+) activity; IEA:EC. | | | | | | | | | | GO:0006703; P:estrogen biosynthetic process; ISS:UniProtKB.::GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW. | 222 | Q7Z5P4 | 300 | DHB13_HUMAN 17-beta-hydroxysteroid dehydrogen... | 252 | 0.00000000000002 | 74.7 | 25 | 46 | GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 223 | Q4L8Y1 | 231 | Y0585_STAHJ Uncharacterized oxidoreductase SH... | 200 | 0.00000000000005 | 72.4 | 27 | 48 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 224 | Q46381 | 281 | BPHB_COMTE Cis-2,3-dihydrobiphenyl-2,3-diol d... | 265 | 0.00000000000005 | 73.2 | 28 | 45 | | | | | | | | | | | GO:0018509; F:cis-2,3-dihydrobiphenyl-2,3-diol dehydrogenase activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW. | 225 | Q92GE0 | 241 | FABG_RICCN 3-oxoacyl-[acyl-carrier-protein] r... | 254 | 0.00000000000007 | 72.4 | 28 | 49 | | | | | | | | | | | GO:0004316; F:3-oxoacyl-[acyl-carrier-protein reductase (NADPH) activity; ISS:UniProtKB.::GO:0051287; F:NAD binding; IEA:InterPro.::GO:0050661; F:NADP binding; ISS:UniProtKB. | | | | | | | | | | GO:0030497; P:fatty acid elongation; ISS:UniProtKB.] | 226 | Q8VCC1 | 269 | PGDH_MOUSE 15-hydroxyprostaglandin dehydrogen... | 243 | 0.00000000000008 | 72.4 | 28 | 48 | GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; ISS:UniProtKB.::GO:0070403; F:NAD+ binding; ISS:UniProtKB.::GO:0004957; F:prostaglandin E receptor activity; ISS:UniProtKB. | | | | | | | | | | GO:0097070; P:ductus arteriosus closure; IMP:UniProtKB.::GO:0007565; P:female pregnancy; ISS:UniProtKB.::GO:0045786; P:negative regulation of cell cycle; ISS:UniProtKB.::GO:0030728; P:ovulation; ISS:UniProtKB.::GO:0007567; P:parturition; ISS:UniProtKB.::GO:0006693; P:prostaglandin metabolic process; ISS:UniProtKB.::GO:0070493; P:thrombin receptor signaling pathway; ISS:UniProtKB.::GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISS:UniProtKB. | 227 | O34896 | 278 | UXUB_BACSU Uncharacterized oxidoreductase uxu... | 287 | 0.0000000000001 | 72.4 | 24 | 43 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 228 | Q4UK62 | 241 | FABG_RICFE 3-oxoacyl-[acyl-carrier-protein] r... | 254 | 0.0000000000001 | 71.6 | 28 | 49 | | | | | | | | | | | GO:0004316; F:3-oxoacyl-[acyl-carrier-protein reductase (NADPH) activity; ISS:UniProtKB.::GO:0051287; F:NAD binding; IEA:InterPro.::GO:0050661; F:NADP binding; ISS:UniProtKB. | | | | | | | | | | GO:0030497; P:fatty acid elongation; ISS:UniProtKB.] | 229 | Q9CQ62 | 335 | DECR_MOUSE 2,4-dienoyl-CoA reductase, mitocho... | 257 | 0.0000000000002 | 72.4 | 26 | 45 | GO:0005739; C:mitochondrion; IDA:MGI. | | | | | | | | | | GO:0008670; F:2,4-dienoyl-CoA reductase (NADPH) activity; IEA:EC. | | | | | | | | | | | 230 | P87025 | 272 | THR1_GLOLA Trihydroxynaphthalene reductase OS... | 247 | 0.0000000000002 | 71.2 | 26 | 46 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | GO:0042438; P:melanin biosynthetic process; IEA:UniProtKB-KW. | 231 | Q56318 | 256 | Y019_THEMA Uncharacterized oxidoreductase TM_... | 255 | 0.0000000000002 | 71.2 | 27 | 49 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 232 | Q64591 | 335 | DECR_RAT 2,4-dienoyl-CoA reductase, mitochond... | 253 | 0.0000000000004 | 71.6 | 25 | 42 | GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0008670; F:2,4-dienoyl-CoA reductase (NADPH) activity; TAS:RGD. | | | | | | | | | | | 233 | O02691 | 261 | HCD2_BOVIN 3-hydroxyacyl-CoA dehydrogenase ty... | 262 | 0.0000000000004 | 70.5 | 26 | 45 | | | | | | | | | | | GO:0047015; F:3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity; IEA:EC.::GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; IEA:EC.::GO:0000166; F:nucleotide binding; IEA:InterPro. | | | | | | | | | | GO:0008033; P:tRNA processing; IEA:UniProtKB-KW. | 234 | P16542 | 272 | DHK1_STRVN Granaticin polyketide synthase put... | 214 | 0.0000000000004 | 70.5 | 29 | 45 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW. | 235 | P33368 | 253 | YOHF_ECOLI Uncharacterized oxidoreductase yoh... | 177 | 0.0000000000004 | 70.1 | 29 | 48 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 236 | P50200 | 267 | HDHA_CLOSO NADP-dependent 7-alpha-hydroxyster... | 260 | 0.0000000000004 | 70.5 | 26 | 48 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | GO:0030573; P:bile acid catabolic process; IEA:UniProtKB-KW. | 237 | O34308 | 255 | YTKK_BACSU Putative oxidoreductase ytkK OS=Ba... | 247 | 0.0000000000006 | 69.7 | 24 | 44 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW. | | | | | | | | | | | 238 | P15428 | 266 | PGDH_HUMAN 15-hydroxyprostaglandin dehydrogen... | 243 | 0.0000000000006 | 70.1 | 28 | 48 | GO:0005829; C:cytosol; NAS:UniProtKB.::GO:0005634; C:nucleus; IDA:HPA. | | | | | | | | | | GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; IDA:UniProtKB.::GO:0070403; F:NAD+ binding; IDA:UniProtKB.::GO:0004957; F:prostaglandin E receptor activity; IDA:UniProtKB.::GO:0042803; F:protein homodimerization activity; TAS:UniProtKB. | | | | | | | | | | GO:0097070; P:ductus arteriosus closure; ISS:UniProtKB.::GO:0007565; P:female pregnancy; IDA:UniProtKB.::GO:0019372; P:lipoxygenase pathway; TAS:UniProtKB.::GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB.::GO:0030728; P:ovulation; ISS:UniProtKB.::GO:0007567; P:parturition; IDA:UniProtKB.::GO:0006693; P:prostaglandin metabolic process; IDA:UniProtKB.::GO:0070493; P:thrombin receptor signaling pathway; ISS:UniProtKB.::GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB. | 239 | O54438 | 247 | FABG_PSEAE 3-oxoacyl-[acyl-carrier-protein] r... | 253 | 0.0000000000007 | 69.7 | 28 | 45 | | | | | | | | | | | GO:0004316; F:3-oxoacyl-[acyl-carrier-protein reductase (NADPH) activity; ISS:UniProtKB.::GO:0051287; F:NAD binding; IEA:InterPro.::GO:0050661; F:NADP binding; ISS:UniProtKB. | | | | | | | | | | GO:0030497; P:fatty acid elongation; ISS:UniProtKB.] | 240 | Q8MJY8 | 266 | PGDH_MACFA 15-hydroxyprostaglandin dehydrogen... | 235 | 0.0000000000008 | 69.7 | 28 | 49 | GO:0005737; C:cytoplasm; IDA:UniProtKB. | | | | | | | | | | GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; ISS:UniProtKB.::GO:0070403; F:NAD+ binding; ISS:UniProtKB.::GO:0004957; F:prostaglandin E receptor activity; ISS:UniProtKB. | | | | | | | | | | GO:0097070; P:ductus arteriosus closure; ISS:UniProtKB.::GO:0007565; P:female pregnancy; ISS:UniProtKB.::GO:0045786; P:negative regulation of cell cycle; ISS:UniProtKB.::GO:0030728; P:ovulation; IEP:UniProtKB.::GO:0007567; P:parturition; ISS:UniProtKB.::GO:0006693; P:prostaglandin metabolic process; ISS:UniProtKB.::GO:0070493; P:thrombin receptor signaling pathway; ISS:UniProtKB.::GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISS:UniProtKB. | 241 | P05707 | 259 | SRLD_ECOLI Sorbitol-6-phosphate 2-dehydrogena... | 262 | 0.0000000000009 | 69.3 | 25 | 45 | | | | | | | | | | | GO:0000166; F:nucleotide binding; IEA:InterPro.::GO:0009010; F:sorbitol-6-phosphate 2-dehydrogenase activity; IEA:EC. | | | | | | | | | | |